Member access

4-Traders Homepage  >  Shares  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

DIASORIN SPA (DIA)

12
Delayed Quote. Delayed CHI-X EUROPE LIMITED. - 12/18 05:24:06 pm
33.4750 EUR   +2.21%
11/11DIASORIN SPA : quaterly earnings release
09/18 DIASORIN : launches the stool test for Adenovirus on LIAISON
08/01 DIASORIN : The Board of Directors approves the results for H1'14
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
12/12/2014 12/15/2014 12/16/2014 12/17/2014 12/18/2014 Date
32.57(c) 32.08(c) 32.62(c) 32.75(c) 33.4 Last
20 405 33 870 85 851 40 446 43 110 Volume
-0.70% -1.50% +1.68% +0.40% +1.98% Change
More quotes
Company
DiaSorin SpA engages in the development and distribution of medical devices.It operates through the Immunodiagnostics and Molecular Diagnostics segments.The Immunodiagnostics segment develops, produces, and markets immunoreagent kits.The Molecular Diagnostics segment supplies end laboratories with... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 443 M
EBIT 2014 135 M
Net income 2014 85,4 M
Finance 2014 38,6 M
Yield 2014 1,56%
Sales 2015 473 M
EBIT 2015 148 M
Net income 2015 94,2 M
Finance 2015 111 M
Yield 2015 1,70%
PER 2014 21,12
PER 2015 18,92
EV / Sales 2014 4,05x
EV / Sales 2015 3,64x
Capitalization 1 832 M
More Financials
Latest news on DIASORIN SPA
11/11DIASORIN SPA : quaterly earnings release
09/18 DIASORIN : launches the stool test for Adenovirus on LIAISON
08/28 DIASORIN : Announces New Webinar in Their Annual Vitamin D Series
08/01 DIASORIN : The Board of Directors approves the results for H1'14
07/22 DIASORIN : Confirms its eligibility for the pea-pme
06/03 DIASORIN : launches the test for Vitamin D 1,25 on LIAISON
05/19 DIASORIN SPA : ex-dividend day for annual dividend
05/09 DIASORIN : The Board of Directors approves the results for Q1'14
More news
Sector news
2h ago BAXTER : to Present at 33rd Annual J.P. Morgan Healthcare Conference
8h ago STRYKER : Study published in the new england journal of medicine finds intra-art..
11h ago SMITH & NEPHEW : study shows incisions managed with unique PICO; NPWT System dem..
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF